Metraipolis › archive › dc_014aba85661f
Evolution of National Influenza Vaccine Platform: From Comprehensive Preclinical Safety Validation of Trivalent Influenza Vaccine to Streamlined… — Europe PMC PMID:42347598
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42347598
- DOI
- 10.3390/vaccines14060477
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:20:41.309Z
- SHA-256 of the archived text
150699eb6236073d26e815e564f68d90857be6a98a587c7b2a8fc373620950c4- Stable URL of this page
https://metraipolis.com/documento/dc_014aba85661f
How to cite
Evolution of National Influenza Vaccine Platform: From Comprehensive Preclinical Safety Validation of Trivalent Influenza Vaccine to Streamlined… — Europe PMC PMID:42347598 — Europe PMC (en), https://europepmc.org/article/MED/42347598 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_014aba85661f (Metraipolis archive dc_014aba85661f, sha256 150699eb6236073d26e815e564f68d90857be6a98a587c7b2a8fc373620950c4)
BibTeX
@misc{dc014aba85661f,
title = {Evolution of National Influenza Vaccine Platform: From Comprehensive Preclinical Safety Validation of Trivalent Influenza Vaccine to Streamlined… — Europe PMC PMID:42347598},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42347598},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_014aba85661f; sha256 150699eb6236073d26e815e564f68d90857be6a98a587c7b2a8fc373620950c4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42347598. Agents can read the archived copy with the MCP tool read_document.